Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in Interest ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Marker Therapeutics (MRKR) Shares Issued (2016 - 2025)

Marker Therapeutics (MRKR) has disclosed Shares Issued for 11 consecutive years, with -$9.9 million as the latest value for Q4 2025.

  • Quarterly Shares Issued fell 269735.81% to -$9.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $605.0 through Dec 2025, down 99.47% year-over-year, with the annual reading at $605.0 for FY2025, 99.03% down from the prior year.
  • Shares Issued for Q4 2025 was -$9.9 million at Marker Therapeutics, down from $9.9 million in the prior quarter.
  • The five-year high for Shares Issued was $52.7 million in Q1 2021, with the low at -$52.5 million in Q3 2021.
  • Average Shares Issued over 5 years is $24156.0, with a median of $21599.0 recorded in 2024.
  • Peak annual rise in Shares Issued hit 45565.44% in 2025, while the deepest fall reached 269735.81% in 2025.
  • Over 5 years, Shares Issued stood at -$52.5 million in 2021, then surged by 100.26% to $138557.0 in 2022, then crashed by 96.29% to $5135.0 in 2023, then decreased by 28.76% to $3658.0 in 2024, then plummeted by 269735.81% to -$9.9 million in 2025.
  • According to Business Quant data, Shares Issued over the past three periods came in at -$9.9 million, $9.9 million, and $100.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.